Corrigendum: miR-21 in Human Cardiomyopathies
Main Authors: | Surina, Rosaria Anna Fontanella, Lucia Scisciola, Raffaele Marfella, Giuseppe Paolisso, Michelangela Barbieri |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-04-01
|
Series: | Frontiers in Cardiovascular Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2022.913429/full |
Similar Items
-
miR-21 in Human Cardiomyopathies
by: Surina, et al.
Published: (2021-10-01) -
Adiponectin Related Vascular and Cardiac Benefits in Obesity: Is There a Role for an Epigenetically Regulated Mechanism?
by: Rosaria Anna Fontanella, et al.
Published: (2021-11-01) -
Therapeutic miR-21 Silencing Reduces Cardiac Fibrosis and Modulates Inflammatory Response in Chronic Chagas Disease
by: Carolina Kymie Vasques Nonaka, et al.
Published: (2021-03-01) -
miR-21-5p prevents doxorubicin-induced cardiomyopathy by downregulating BTG2
by: Qingwei Wang, et al.
Published: (2023-05-01) -
Therapeutic inhibition of microRNA-21 (miR-21) using locked-nucleic acid (LNA)-anti-miR and its effects on the biological behaviors of melanoma cancer cells in preclinical studies
by: Shaghayegh Haghjooy Javanmard, et al.
Published: (2020-08-01)